[1]
|
Manfredi, S., Lepage, C., Hatem, C., et al. (2006) Epidemiology and Management of Liver Metastases from Colorectal Cancer. Annals of Surgery, 244, 254-259. https://doi.org/10.1097/01.sla.0000217629.94941.cf
|
[2]
|
Parkin, D.M., Bray, F., Ferlay, J., et al. (2005) Global Cancer Statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
|
[3]
|
Nordlinger, B., Van Cutsem, E., Rougier, P., et al. (2007) Does Chemotherapy Prior to Liver Resection Increase the Potential for Cure in Patients with Metastatic Colorectal Cancer? A Report from the European Colorectal Metastases Treatment Group. European Journal of Cancer, 43, 2037-2045.
|
[4]
|
Berber, E., Pelley, R. and Siperstein, A.E. (2005) Predictors of Survival after Radiofrequency Thermal Ablation of Colorectal Cancer Metastases to the Liver: A Prospective Study. Journal of Clinical Oncology, 23, 1358-1364.
https://doi.org/10.1200/JCO.2005.12.039
|
[5]
|
Van Cutsem, E., Nordlinger, B., Adam, R., et al. (2006) Towards a Pan-European Consensus on the Treatment of Patients with Colorectal Liver Metastases. European Journal of Cancer, 42, 2212-2221.
|
[6]
|
Navarra, G., Ayav, A., Weber, J.C., et al. (2005) Short-and-Long Term Results of Intraoperative Radiofrequency Ablation of Liver Metastases. International Journal of Colorectal Disease, 20, 521-528.
https://doi.org/10.1007/s00384-005-0743-4
|
[7]
|
Rothbarth, J. and van de Velde, C.J. (2005) Treatment of Liver Metastases of Colorectal Cancer. Annals of Oncology, 16, ii144-ii149. https://doi.org/10.1093/annonc/mdi702
|
[8]
|
Kennedy, A.S., Coldwell, D., Nutting, C., et al. (2006) Resin 90Y-Microsphere Brachytherapy for Unresectable Colorectal Liver Metastases: Modern USA Experience. International Journal of Radiation Oncology, Biology, Physics, 65, 412-425. https://doi.org/10.1016/j.ijrobp.2005.12.051
|
[9]
|
Szyszko, T., Al-Nahhas, A., Tait, P., et al. (2007) Management and Prevention of Adverse Effects Related to Treatment of Liver Tumours with 90Y Microspheres. Nuclear Medicine Communications, 28, 21-24.
https://doi.org/10.1097/MNM.0b013e3280121a8f
|
[10]
|
Jakobs, T.F., Hoffmann, R.T., Poepperl, G., et al. (2007) Mid-Term Results in Otherwise Treatment Refractory Primary or Secondary Liver Confined Tumours Treated with Selective Internal Radiation Therapy (SIRT) Using 90Yttrium Resin-Microspheres. European Radiology, 17, Article No. 1320. https://doi.org/10.1007/s00330-006-0508-7
|
[11]
|
Campbell, A.M., Bailey, I.H. and Burton, M.A. (2001) Tumour Dosimetry in Human Liver Following Hepatic Yttrium-90 Microsphere Therapy. Physics in Medicine and Biology, 46, 487-498.
https://doi.org/10.1088/0031-9155/46/2/315
|
[12]
|
Kennedy, A., Nag, S., Salem, R., et al. (2007) Recommendations for Radioembolization of Hepatic Malignancies Using Yttrium-90 Microsphere Brachytherapy: A Consensus Panel Report from the Radioembolization Brachytherapy Oncology Consortium. International Journal of Radiation Oncology, Biology, Physics, 68, 13-23.
https://doi.org/10.1016/j.ijrobp.2006.11.060
|
[13]
|
Hirata, A., Hirotsu, Y., Nieh, T.G., et al. (2007) Direct Imaging of Local Atomic Ordering in a Pd-Ni-P Bulk Metallic Glass Using Cs-Corrected Transmission Electron Microscopy. Ultramicroscopy, 107, 116-123.
https://doi.org/10.1016/j.ultramic.2006.06.002
|
[14]
|
Kennedy, A.S., Nutting, C., Coldwell, D., et al. (2004) Pathologic Response and Microdosimetry of (90)Y Microspheres in Man: Review of Four Explanted Whole Livers. International Journal of Radiation Oncology, Biology, Physics, 60, 1552-1563. https://doi.org/10.1016/j.ijrobp.2004.09.004
|
[15]
|
Gulec, S.A., Pennington, K., Wheeler, J., et al. (2013) Yttrium-90 Microsphere-Selective Internal Radiation Therapy with Chemotherapy (Chemo-SIRT) for Colorectal Cancer Liver Metastases: An in Vivo Double-Arm-Controlled Phase II Trial. American Journal of Clinical Oncology, 36, 455-460. https://doi.org/10.1097/COC.0b013e3182546c50
|
[16]
|
Chua, T.C., Bester, L., Saxena, A., et al. (2011) Radioembolization and Systemic Chemotherapy Improves Response and Survival for Unresectable Colorectal Liver Metastases. Journal of Cancer Research and Clinical Oncology, 137, 865-873. https://doi.org/10.1007/s00432-010-0948-y
|
[17]
|
Kosmider, S., Tan, T.H., Yip, D., et al. (2011) Radioembolization in Combination with Systemic Chemotherapy as First-Line Therapy for Liver Metastases from Colorectal Cancer. Journal of Vascular and Interventional Radiology: JVIR, 22, 780-786. https://doi.org/10.1016/j.jvir.2011.02.023
|
[18]
|
Cohen, S.J., Konski, A.A., Putnam, S., et al. (2014) Phase I Study of Capecitabine Combined with Radioembolization Using Yttrium-90 Resin Microspheres (SIR-Spheres) in Patients with Advanced Cancer. British Journal of Cancer, 111, 265-271. https://doi.org/10.1038/bjc.2014.344
|
[19]
|
Hendlisz, A., Van den Eynde, M., Peeters, M., et al. (2010) Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or with Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy. Journal of Clinical Oncology, 28, 3687-3694.
https://doi.org/10.1200/JCO.2010.28.5643
|
[20]
|
Gray, B., Van Hazel, G., Hope, M., et al. (2001) Randomised Trial of SIR-Spheres Plus Chemotherapy vs. Chemotherapy Alone for Treating Patients with Liver Metastases from Primary Large Bowel Cancer. Annals of Oncology, 12, 1711-1720. https://doi.org/10.1023/A:1013569329846
|
[21]
|
Van Hazel, G., Blackwell, A., Anderson, J., et al. (2004) Randomised Phase 2 Trial of SIR-Spheres Plus Fluorouracil/Leucovorin Chemotherapy versus Fluorouracil/Leucovorin Chemotherapy Alone in Advanced Colorectal Cancer. Journal of Surgical Oncology, 88, 78-85. https://doi.org/10.1002/jso.20141
|
[22]
|
Wasan, H.S., Gibbs, P., Sharma, N.K., et al. (2017) First-Line Selective Internal Radiotherapy Plus Chemotherapy versus Chemotherapy Alone in Patients with Liver Metastases from Colorectal Cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): A Combined Analysis of Three Multicentre, Randomised, Phase 3 Trials. The Lancet Oncology, 18, 1159-1171. https://doi.org/10.1016/S1470-2045(17)30457-6
|
[23]
|
Jakobs, T.F., Hoffmann, R.T., Dehm, K., et al. (2008) Hepatic Yttrium-90 Radioembolization of Chemotherapy-Refractory Colorectal Cancer Liver Metastases. Journal of Vascular and Interventional Radiology: JVIR, 19, 1187-1195.
https://doi.org/10.1016/j.jvir.2008.05.013
|
[24]
|
Chun, Y.S., Laurent, A., Maru, D., et al. (2009) Management of Chemotherapy-Associated Hepatotoxicity in Colorectal Liver Metastases. The Lancet Oncology, 10, 278-286. https://doi.org/10.1016/S1470-2045(09)70064-6
|
[25]
|
Nordlinger, B., Sorbye, H., Glimelius, B., et al. (2008) Perioperative Chemotherapy with FOLFOX4 and Surgery versus Surgery Alone for Resectable Liver Metastases from Colorectal Cancer (EORTC Intergroup Trial 40983): A Randomised Controlled Trial. The Lancet, 371, 1007-1016. https://doi.org/10.1016/S0140-6736(08)60455-9
|
[26]
|
Folprecht, G., Grothey, A., Alberts, S., et al. (2005) Neoadjuvant Treatment of Unresectable Colorectal Liver Metastases: Correlation between Tumour Response and Resection Rates. Annals of Oncology, 16, 1311-1319.
https://doi.org/10.1093/annonc/mdi246
|
[27]
|
Alberts, S.R., Horvath, W.L., Sternfeld, W.C., et al. (2005) Oxaliplatin, Fluorouracil, and Leucovorin for Patients with Unresectable Liver-Only Metastases from Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study. Journal of Clinical Oncology, 23, 9243-9249. https://doi.org/10.1200/JCO.2005.07.740
|
[28]
|
Bujko, K., Nasierowska-Guttmejer, A., Wyrwicz, L., et al. (2013) Neoadjuvant Treatment for Unresectable Rectal Cancer: An Interim Analysis of a Multicentre Randomized Study. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 107, 171-177. https://doi.org/10.1016/j.radonc.2013.03.001
|
[29]
|
Myerson, R.J., Tan, B., Hunt, S., et al. (2014) Five Fractions of Radiation Therapy Followed by 4 Cycles of FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer. International Journal of Radiation Oncology, Biology, Physics, 88, 829-836. https://doi.org/10.1016/j.ijrobp.2013.12.028
|
[30]
|
Radu, C., Berglund, A., Påhlman, L., et al. (2008) Short-Course Preoperative Radiotherapy with Delayed Surgery in Rectal Cancer—A Retrospective Study. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 87, 343-349. https://doi.org/10.1016/j.radonc.2007.11.025
|
[31]
|
van Dijk, T.H., Tamas, K., Beukema, J.C., et al. (2013) Evaluation of Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Surgical Treatment in Primary Stage IV Rectal Cancer. Annals of Oncology, 24, 1762-1769. https://doi.org/10.1093/annonc/mdt124
|
[32]
|
An, H.J., Yu, C.S., Yun, S.C., et al. (2012) Adjuvant Chemotherapy with or without Pelvic Radiotherapy after Simultaneous Surgical Resection of Rectal Cancer with Liver Metastases: Analysis of Prognosis and Patterns of Recurrence. International Journal of Radiation Oncology, Biology, Physics, 84, 73-80. https://doi.org/10.1016/j.ijrobp.2011.10.070
|
[33]
|
Assumpcao, L., Choti, M.A., Gleisner, A.L., et al. (2008) Patterns of Recurrence Following Liver Resection for Colorectal Metastases: Effect of Primary Rectal Tumor Site. Archives of Surgery, 143, 743-749.
https://doi.org/10.1001/archsurg.143.8.743
|
[34]
|
Kim, T.W., Lee, J.H., Lee, J.H., et al. (2011) Randomized Trial of Postoperative Adjuvant Therapy in Stage II and III Rectal Cancer to Define the Optimal Sequence of Chemotherapy and Radiotherapy: 10-Year Follow-Up. International Journal of Radiation Oncology, Biology, Physics, 81, 1025-1031. https://doi.org/10.1016/j.ijrobp.2010.07.012
|
[35]
|
Lee, J.H., Lee, J.H., Ahn, J.H., et al. (2002) Randomized Trial of Postoperative Adjuvant Therapy in Stage II and III Rectal Cancer to Define the Optimal Sequence of Chemotherapy and Radiotherapy: A Preliminary Report. Journal of Clinical Oncology, 20, 1751-1758. https://doi.org/10.1200/JCO.2002.07.037
|